Janus Henderson Group plc 13D and 13G filings for Larimar Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-08 11:49 am Purchase | 2024-12-31 | 13G | Larimar Therapeutics, Inc. LRMR | JANUS HENDERSON GROUP PLC JHG | 6,443,286 10.100% | 876,431 (+15.74%) | Filing |
| 2024-11-14 11:41 am Purchase | 2024-09-30 | 13G | Larimar Therapeutics, Inc. LRMR | JANUS HENDERSON GROUP PLC JHG | 5,566,855 8.700% | 2,925,790 (+110.78%) | Filing |
| 2024-02-13 5:31 pm Purchase | 2023-12-31 | 13G | Larimar Therapeutics, Inc. LRMR | JANUS HENDERSON GROUP PLC JHG | 2,641,065 6.000% | 449,654 (+20.52%) | Filing |
| 2023-08-18 2:45 pm Purchase | 2023-08-10 | 13G | Larimar Therapeutics, Inc. LRMR | JANUS HENDERSON GROUP PLC JHG | 2,191,411 5.100% | 2,191,411 (New Position) | Filing |